Why Hellmann Mexico is ready for the increasing healthcare logistics demands

  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share on Pinterest
  • Share on Blogger

Mexico is the second largest healthcare market in Latin America and the eighth in the world for production. It also has nearly half of the top CROs (Clinical Trial Organizations) operating significant clinical trials including Covid-19 vaccine candidates in Mexico and the region.

“Since early this year, we’ve taken major steps to prepare Hellmann Mexico to support Mexico’s increasing time and temperature sensitive healthcare logistics demands,” Piotr Zaleski, CEO & president Hellmann Worldwide Logistics Latin America says. He adds, “Besides all other necessary technical knowledge for our team members, it is about enhancing our infrastructure, quality systems, and digital solutions.”

With GDP (Good Distribution Practice) compliant vendor management, Hellmann’s QHSE head of the region qualifies carriers and handlers to be able to confidently transport all temperature control requirements and growing medical device commodities. The need for these solutions is directly linked with Hellmann’s real time visibility platform Hellmann Smart Visibility, its neutral 4PL control tower, and various temperature controlled packaging solutions, which help carry out the process.

Aldo Aguilar, head of Healthcare Vertical Hellmann Mexico, says, “Many executives of medical device companies tell us the double-digit growth but its subsequent challenges especially with Covid-19 related capacity constraints, now and later when the vaccines become available.” Often these medical device companies export to other Latin American countries, USA, and Europe where Hellmann Healthcare Logistics Network is well established as well. “Supported by hundreds of Hellmann Healthcare Logistics specialists in overseas, Hellmann Mexico’s investment and commitment to Mexican healthcare industry will continue to support its ongoing export and import growths and preparation for Covid-19 vaccine logistics,” adds Zaleski.

  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share on Pinterest
  • Share on Blogger